Clinical Trial Update: Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring HGF gene therapy for improving angiogenesis and blood perfusion in peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• HGF gene therapy (hepatocyte growth factor gene therapy)

Snippet

Sponsor: Beijing Northland Biotech. Co., Ltd. | Conditions: Peripheral Artery Disease | Phase 3 | Status: UNKNOWN